Nektar Therapeutics
NKTR
#4623
Rank
HK$18.49 B
Marketcap
HK$547.50
Share price
6.76%
Change (1 day)
169.91%
Change (1 year)

EPS for Nektar Therapeutics (NKTR)

EPS in 2025 (TTM): -HK$79.57

According to Nektar Therapeutics 's latest financial reports the company's current EPS (TTM) is -HK$80.00. In 2024 the company made an earnings per share (EPS) of -HK$69.49 an increase over its 2023 EPS that were of -HK$171.75.

EPS history for Nektar Therapeutics from 2012 to 2025

Annual EPS

Year EPS Change
2025 (TTM)-HK$79.5714.51%
2024-HK$69.49-59.54%
2023-HK$171.75-25.89%
2022-HK$231.75-31.12%
2021-HK$336.4514.86%
2020-HK$292.92-1.19%
2019-HK$296.45-163.96%
2018HK$463.50-725.4%
2017-HK$74.11-42.73%
2016-HK$129.4083.33%
2015-HK$70.5839.53%
2014-HK$50.59-69.29%
2013-HK$164.70-6.67%
2012-HK$176.46

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
HK$68.52-185.65%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
HK$10.27-112.84%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
HK$113.56-241.96%๐Ÿ‡บ๐Ÿ‡ธ USA
Baxter
BAX
-HK$16.70-79.12%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
HK$27.90-134.88%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
HK$54.51-168.14%๐Ÿ‡ฌ๐Ÿ‡ง UK
Richardson Electronics
RELL
HK$0.55-100.69%๐Ÿ‡บ๐Ÿ‡ธ USA
Alkermes
ALKS
HK$7.29-109.12%๐Ÿ‡ฎ๐Ÿ‡ช Ireland